マサチューセッツ州における統合失調症の臨床試験
マサチューセッツ州内の拠点で、統合失調症に関する22件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Boston Medical Center, Boston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/30更新 · NCT07101094NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Boston
- Neurocrine Clinical Site, Watertown
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Boston
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Boston Children's Hospital, Boston
- Local Institution - 0132, Lexington
- Local Institution - 0059, Worcester
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/22更新 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- McLean Hospital, Belmont
- Adams Clinical Watertown, Watertown
- University of Massachusetts Chan Medical School, Worcester
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/09/22更新 · NCT07410507A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Boston Children's Hospital, Boston
- Local Institution - 0059, Worcester
被験者募集中第3相
13歳〜17歳 · 全性別 · 2026/09/04更新 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Boston
- Clinical Site, Watertown
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT07459647Cerebellar Modulation of Cognition in Psychosis
- McLean Hospital, Belmont
- Beth Israel Deaconess Medical Center, Boston
被験者募集中
18歳〜55歳 · 全性別 · 2026/08/20更新 · NCT06107764Biomarkers to Enhance Early Schizophrenia Treatment
- McLean, Belmont
被験者募集中第4相
18歳〜35歳 · 全性別 · 2026/07/31更新 · NCT06969755Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
- Massachusetts General Hospital, Charlestown
被験者募集中健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/07/16更新 · NCT04940663Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
- UMass Chan Medical School, Worcester
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/05/22更新 · NCT06174116CLOZAPINE Response in Biotype-1
- Beth Israel Deaconess Medical Center, Boston
被験者募集中第4相
18歳〜60歳 · 全性別 · 2026/05/11更新 · NCT04580134Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- McLean Hospital, Belmont
- Beth Israel Deaconess Medical Center, Boston
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Watertown
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/03/06更新 · NCT06963034Enhanced Coordinated Specialty Care for Early Psychosis
- McLean Hospital OnTrack Clinic, Belmont
- Massachusetts General Hospital FEPP Clinic, Boston
- Boston Medical Center WRAP, Boston
- 他2件
被験者募集中
全年齢 · 全性別 · 2026/02/27更新 · NCT06071858Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
- McLean Hospital, Belmont
被験者募集中
18歳〜55歳 · 全性別 · 2026/01/22更新 · NCT05343598Study of ALTO-101 in Patients With Schizophrenia
- Site 5124, Belmont
被験者募集中第2相
21歳〜55歳 · 全性別 · 2025/12/26更新 · NCT06502964MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
- McLean Hospital, Belmont
被験者募集中第2/3相
18歳〜35歳 · 全性別 · 2025/09/25更新 · NCT06191965Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
- Boston VA Healthcare System, Brockton, Brockton
被験者募集中
18歳〜55歳 · 全性別 · 2025/09/18更新 · NCT05299749Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
- Massachusetts General Hospital, Boston
被験者募集中健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2025/09/10更新 · NCT04296604The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
- Massachusetts General Hospital, Charlestown
被験者募集中健康なボランティア歓迎
18歳〜45歳 · 全性別 · 2025/05/14更新 · NCT06386588Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Boston
被験者募集中第3相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2024/12/19更新 · NCT05184335ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。